Your browser doesn't support javascript.
loading
Dual therapeutic approach to modulate Glycogen Synthase kinase -3 beta (GSK-3Β) and inhibitor of nuclear factor kappa kinase-beta (IKK-ß) receptors by in silico designing of inhibitors.
Roy Acharyya, Suchandra; Sen, Plaboni; Kandasamy, Thirukumaran; Sankar Ghosh, Siddhartha.
Affiliation
  • Roy Acharyya S; Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati-39, Assam, India.
  • Sen P; Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati-39, Assam, India.
  • Kandasamy T; Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati-39, Assam, India.
  • Sankar Ghosh S; Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati-39, Assam, India; Centre for Nanotechnology, Indian Institute of Technology Guwahati, Guwahati-39, Assam, India. Electronic address: sghosh@iitg.ac.in.
J Mol Graph Model ; 115: 108225, 2022 09.
Article in En | MEDLINE | ID: mdl-35636338
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Enzyme Inhibitors / I-kappa B Kinase Type of study: Prognostic_studies Language: En Journal: J Mol Graph Model Journal subject: BIOLOGIA MOLECULAR Year: 2022 Document type: Article Affiliation country: India
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Enzyme Inhibitors / I-kappa B Kinase Type of study: Prognostic_studies Language: En Journal: J Mol Graph Model Journal subject: BIOLOGIA MOLECULAR Year: 2022 Document type: Article Affiliation country: India